Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS · Delayed Price · Currency is USD
5.00
+0.49 (10.86%)
At close: Oct 17, 2025
HNSPF Market Cap
HNSPF has a market cap or net worth of $32.71 billion as of December 8, 2025. Its market cap has increased by 151.25% in one year.
Market Cap
32.71B
Enterprise Value
28.91B
Revenue
1.84B
Ranking
n/a
PE Ratio
49.01
Stock Price
$5.00
Market Cap Chart
Since June 14, 2019, HNSPF's market cap has increased from 14.22B to 32.71B, an increase of 130.09%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 32.71B | 147.76% |
| Dec 31, 2024 | 13.20B | 10.47% |
| Dec 29, 2023 | 11.95B | 6.05% |
| Dec 30, 2022 | 11.27B | -21.91% |
| Dec 31, 2021 | 14.43B | -49.73% |
| Dec 31, 2020 | 28.70B | 49.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.88M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |